Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Evolent Health, Inc.EVH · Entity 5492 | Director | June 04, 2026 | June 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Evolent Health, Inc.
Report date June 04, 2026 · Filed June 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 77,347 |
Reported balance
After 2026-06-04 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-04 · Grant · Acquired 41,096 · Balance 77,347 F1: Represents restricted stock units granted to Mr. Glass pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2: Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy trust | 6,046 |
Reported balance
Holding disclosure · report date 2026-06-04 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 6,046 F3: These shares are held in a trust for the benefit of the reporting person and his spouse. The reporting person and his spouse are co-trustees of the trust and share voting and dispositive power over the shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units granted to Mr. Glass pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
F2: Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date.
F3: These shares are held in a trust for the benefit of the reporting person and his spouse. The reporting person and his spouse are co-trustees of the trust and share voting and dispositive power over the shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 04, 2026 Filed Jun 8, 2026 20:28 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 41,096 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-26-000055 · wk-form4_1780950501.xml · nonDerivative · entry 1 Glass Russell Monroe · CIK 0002012340 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,347 F1 · security: Represents restricted stock units granted to Mr. Glass pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 11:11 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 21,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-25-000084 · wk-form4_1749467505.xml · nonDerivative · entry 1 Glass Russell Monroe · CIK 0002012340 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,251 F1 · security: Represents restricted stock units granted to Mr. Glass pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of June 5, 2026, and the date of the Company's 2026 annual meeting, subject to the reporting person's continued service on the vesting date. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 12:07 UTC | Evolent Health, Inc. EVH · Entity 5492 | PurchaseClass A Common Stock | 5,400 | $9.27 | $50,058.00 |
DisclosureSEC source: 0001628908-25-000040 · wk-form4_1741608419.xml · nonDerivative · entry 1 Glass Russell Monroe · CIK 0002012340 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,272 F1 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 23:33 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 7,709 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-24-000072 · wk-form4_1718062406.xml · nonDerivative · entry 1 Glass Russell Monroe · CIK 0002012340 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,872 F1 · security: Represents restricted stock units granted to Mr. Glass pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of June 6, 2025, and the date of the Company's 2025 annual meeting, subject to the reporting person's continued service on the vesting date. Read SEC document |
| March 01, 2024 Filed Mar 6, 2024 00:24 UTC | Evolent Health, Inc. EVH · Entity 5492 | GrantClass A Common Stock | 1,163 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-24-000042 · wk-form4_1709684662.xml · nonDerivative · entry 1 Glass Russell Monroe · CIK 0002012340 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,163 F1 · security: Represents restricted stock units granted to Mr. Glass pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of March 1, 2025 and the date of the Company's 2024 annual meeting, subject to the reporting person's continued service on the vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.